UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects

Radiation oncology (London, England), 2019-01, Vol.14 (1), p.21-11, Article 21

2019

Volltextzugriff (PDF)

Progression and metastasis of lung cancer

Cancer and metastasis reviews, 2016-03, Vol.35 (1), p.75-91

Popper, Helmut H.

2016

Volltextzugriff (PDF)

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3439-3446

2015

Volltextzugriff (PDF)

Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer

Molecular oncology, 2020-11, Vol.14 (11), p.2853-2867

2020

Volltextzugriff (PDF)

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

The New England journal of medicine, 2006-09, Vol.355 (10), p.983-991

2006

Volltextzugriff (PDF)

Fibrosing pneumonia – how to diagnose, and how to recognize the etiology?

Surgical and experimental pathology, 2020-07, Vol.3 (1), p.1-25, Article 15

Popper, Helmut H.-

2020

Volltextzugriff (PDF)

Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma

Molecular therapy. Nucleic acids, 2019-06, Vol.16, p.543-553

2019

Volltextzugriff (PDF)

Causes of pulmonary granulomas: a retrospective study of 500 cases from seven countries

Journal of clinical pathology, 2012-01, Vol.65 (1), p.51-57

2012

Volltextzugriff (PDF)

Pathologists and liquid biopsies: to be or not to be?

Virchows Archiv, 2016-12, Vol.469 (6), p.601-609

2016

Volltextzugriff (PDF)

Cell Cycle Regulators and Outcome of Adjuvant Cisplatin-Based Chemotherapy in Completely Resected Non–Small-Cell Lung Cancer: The International Adjuvant Lung Cancer Trial Biologic Program

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2735-2740

2007

Volltextzugriff (PDF)

Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients with Completely Resected Non–Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program

Clinical cancer research, 2007-07, Vol.13 (13), p.3892-3898

2007

Volltextzugriff (PDF)

Manipulation of the immune system by non-small cell lung cancer and possible therapeutic interference

Cancer Drug Resistance, 2020-01

Popper, Helmut H.

2020

Volltextzugriff (PDF)

The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: New potential therapeutic targets?

Lung cancer (Amsterdam, Netherlands), 2009-07, Vol.65 (1), p.49-55

2009

Volltextzugriff (PDF)

Lung adenocarcinomas: comparison between mice and men

Methods in molecular biology (Clifton, N.J.), 2015, Vol.1267, p.19

Popper, Helmut H

2015

Volltextzugriff (PDF)

Commentary on tumor heterogeneity

Translational lung cancer research, 2016-08, Vol.5 (4), p.433-435

Popper, Helmut H.

2016

Volltextzugriff (PDF)

BAP1 Protein is a Progression Factor in Malignant Pleural Mesothelioma

Pathology oncology research, 2014, Vol.20 (1), p.145-151

2014

Volltextzugriff (PDF)

Pathological and imaging features of pulmonary invasive mucinous adenocarcinoma—a retrospective cohort study

Translational lung cancer research, 2024-06, Vol.13 (6), p.1376-1382

2024

Volltextzugriff (PDF)

Cons: the confusing mucinous adenocarcinoma classification

Translational lung cancer research, 2017-04, Vol.6 (2), p.234-240

Popper, Helmut H.

2017

Volltextzugriff (PDF)

Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition

Scientific reports, 2017-08, Vol.7 (1), p.10040-11, Article 10040

2017

Volltextzugriff (PDF)

Interstitial lung diseases—can pathologists arrive at an etiology-based diagnosis? A critical update

Virchows Archiv : an international journal of pathology, 2013-01, Vol.462 (1), p.1-26

Popper, Helmut H.

2013

Volltextzugriff (PDF)

Pulmonary mucinous adenocarcinomas: architectural patterns in correlation with genetic changes, prognosis and survival

Virchows Archiv : an international journal of pathology, 2015-12, Vol.467 (6), p.675-686

2015

Volltextzugriff (PDF)

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung

Virchows Archiv : an international journal of pathology, 2018-04, Vol.472 (4), p.589-598

2018

Volltextzugriff (PDF)

Abstract 5134: Evaluation of immune tolerance mechanisms in pulmonary squamous cell and adenocarcinomas - how to interfere beyond PDL1 blockade

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.5134-5134

2016

Volltextzugriff (PDF)

MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non―Small Cell Lung Carcinoma

Cancer research (Chicago, Ill.), 2010-11, Vol.70 (21), p.8288-8298

2010

Volltextzugriff (PDF)

Rebuttal from Professor Helmut H. Popper

Translational lung cancer research, 2017-04, Vol.6 (2), p.243-245

Popper, Helmut H.

2017

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(136)

Publikationsform

Sprache

Englisch
(151)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects

Progression and metastasis of lung cancer

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection

Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

Fibrosing pneumonia – how to diagnose, and how to recognize the etiology?

Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma

Causes of pulmonary granulomas: a retrospective study of 500 cases from seven countries

Pathologists and liquid biopsies: to be or not to be?

Cell Cycle Regulators and Outcome of Adjuvant Cisplatin-Based Chemotherapy in Completely Resected Non–Small-Cell Lung Cancer: The International Adjuvant Lung Cancer Trial Biologic Program

Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients with Completely Resected Non–Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program

Manipulation of the immune system by non-small cell lung cancer and possible therapeutic interference

The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: New potential therapeutic targets?

Lung adenocarcinomas: comparison between mice and men

Commentary on tumor heterogeneity

BAP1 Protein is a Progression Factor in Malignant Pleural Mesothelioma

Pathological and imaging features of pulmonary invasive mucinous adenocarcinoma—a retrospective cohort study

Cons: the confusing mucinous adenocarcinoma classification

Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition

Interstitial lung diseases—can pathologists arrive at an etiology-based diagnosis? A critical update

Pulmonary mucinous adenocarcinomas: architectural patterns in correlation with genetic changes, prognosis and survival

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung

Abstract 5134: Evaluation of immune tolerance mechanisms in pulmonary squamous cell and adenocarcinomas - how to interfere beyond PDL1 blockade

MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non―Small Cell Lung Carcinoma

Rebuttal from Professor Helmut H. Popper

Suchergebnisse filtern